97 related articles for article (PubMed ID: 27905004)
21. Solid lipid nanoparticles for ocular drug delivery.
Seyfoddin A; Shaw J; Al-Kassas R
Drug Deliv; 2010; 17(7):467-89. PubMed ID: 20491540
[TBL] [Abstract][Full Text] [Related]
22. [Design of Novel Ophthalmic Formulation Containing Drug Nanoparticles and Its Usefulness as Anti-glaucoma Drugs].
Nagai N
Yakugaku Zasshi; 2016; 136(10):1385-1390. PubMed ID: 27725388
[TBL] [Abstract][Full Text] [Related]
23. Ocular Disposition of ∆
Punyamurthula NS; Adelli GR; Gul W; Repka MA; ElSohly MA; Majumdar S
AAPS PharmSciTech; 2017 Aug; 18(6):1936-1945. PubMed ID: 27905004
[TBL] [Abstract][Full Text] [Related]
24. Topical ophthalmic lipid nanoparticle formulations (SLN, NLC) of indomethacin for delivery to the posterior segment ocular tissues.
Balguri SP; Adelli GR; Majumdar S
Eur J Pharm Biopharm; 2016 Dec; 109():224-235. PubMed ID: 27793755
[TBL] [Abstract][Full Text] [Related]
25. Fabrication of a composite system combining solid lipid nanoparticles and thermosensitive hydrogel for challenging ophthalmic drug delivery.
Hao J; Wang X; Bi Y; Teng Y; Wang J; Li F; Li Q; Zhang J; Guo F; Liu J
Colloids Surf B Biointerfaces; 2014 Feb; 114():111-20. PubMed ID: 24176890
[TBL] [Abstract][Full Text] [Related]
26. Fabrication and evaluation of lipid nanoparticulates for ocular delivery of a COX-2 inhibitor.
Sharma AK; Sahoo PK; Majumdar DK; Sharma N; Sharma RK; Kumar A
Drug Deliv; 2016 Nov; 23(9):3364-3373. PubMed ID: 27128623
[TBL] [Abstract][Full Text] [Related]
27. Development of a Δ9-Tetrahydrocannabinol Amino Acid-Dicarboxylate Prodrug With Improved Ocular Bioavailability.
Adelli GR; Bhagav P; Taskar P; Hingorani T; Pettaway S; Gul W; ElSohly MA; Repka MA; Majumdar S
Invest Ophthalmol Vis Sci; 2017 Apr; 58(4):2167-2179. PubMed ID: 28399267
[TBL] [Abstract][Full Text] [Related]
28. Development and characterization of mucoadhesive chitosan films for ophthalmic delivery of cyclosporine A.
Hermans K; Van den Plas D; Kerimova S; Carleer R; Adriaensens P; Weyenberg W; Ludwig A
Int J Pharm; 2014 Sep; 472(1-2):10-9. PubMed ID: 24929014
[TBL] [Abstract][Full Text] [Related]
29. Nanoparticles in the ocular drug delivery.
Zhou HY; Hao JL; Wang S; Zheng Y; Zhang WS
Int J Ophthalmol; 2013; 6(3):390-6. PubMed ID: 23826539
[TBL] [Abstract][Full Text] [Related]
30. Ocular disposition of the hemiglutarate ester prodrug of ∆⁹-Tetrahydrocannabinol from various ophthalmic formulations.
Hingorani T; Adelli GR; Punyamurthula N; Gul W; Elsohly MA; Repka MA; Majumdar S
Pharm Res; 2013 Aug; 30(8):2146-56. PubMed ID: 23737345
[TBL] [Abstract][Full Text] [Related]
31. Indomethacin-loaded solid lipid nanoparticles for ocular delivery: development, characterization, and in vitro evaluation.
Hippalgaonkar K; Adelli GR; Hippalgaonkar K; Repka MA; Majumdar S
J Ocul Pharmacol Ther; 2013 Mar; 29(2):216-28. PubMed ID: 23421502
[TBL] [Abstract][Full Text] [Related]
32. Ocular insert for sustained delivery of gatifloxacin sesquihydrate: Preparation and evaluations.
Khurana G; Arora S; Pawar PK
Int J Pharm Investig; 2012 Apr; 2(2):70-7. PubMed ID: 23119235
[TBL] [Abstract][Full Text] [Related]
33. The molecular basis of retinal ganglion cell death in glaucoma.
Almasieh M; Wilson AM; Morquette B; Cueva Vargas JL; Di Polo A
Prog Retin Eye Res; 2012 Mar; 31(2):152-81. PubMed ID: 22155051
[TBL] [Abstract][Full Text] [Related]
34. Effect of ion pairing on in vitro transcorneal permeability of a Δ(9) -tetrahydrocannabinol prodrug: potential in glaucoma therapy.
Hingorani T; Gul W; Elsohly M; Repka MA; Majumdar S
J Pharm Sci; 2012 Feb; 101(2):616-26. PubMed ID: 21989812
[TBL] [Abstract][Full Text] [Related]
35. Enhanced solubility, stability, and transcorneal permeability of δ-8-tetrahydrocannabinol in the presence of cyclodextrins.
Hippalgaonkar K; Gul W; ElSohly MA; Repka MA; Majumdar S
AAPS PharmSciTech; 2011 Jun; 12(2):723-31. PubMed ID: 21637944
[TBL] [Abstract][Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
